Johnson & Johnson Revenue 2007–2025
Johnson & Johnson reported $94.19B of revenue for fiscal 2025. That was 6.0% higher than fiscal 2024. Compared with fiscal 2019, the change was +14.8%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $94.19B | +6.0% |
| FY 2024 | $88.82B | +4.3% |
| FY 2023 | $85.16B | -10.3% |
| FY 2022 | $94.94B | +20.6% |
| FY 2022 | $78.74B | -4.7% |
| FY 2021 | $82.58B | +0.6% |
| FY 2019 | $82.06B | +0.6% |
| FY 2018 | $81.58B | +6.7% |
| FY 2017 | $76.45B | +6.3% |
| FY 2017 | $71.89B | — |
| FY 2016 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
| FY 2012 | $0 | — |
| FY 2012 | $0 | — |
| FY 2011 | $0 | — |
| FY 2010 | $0 | — |
| FY 2008 | $0 | — |
| FY 2007 | $0 | — |
Source: Johnson & Johnson SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open JNJ 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Johnson & Johnson reported $94.19B of revenue for fiscal 2025. That was 6.0% higher than fiscal 2024. Compared with fiscal 2019, the change was +14.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Johnson & Johnson
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeJohnson & Johnson — frequently asked questions
What is Johnson & Johnson's revenue?
Johnson & Johnson (JNJ) reported revenue of $94.19B for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Johnson & Johnson's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.